Price M, Ballard C, Benedetti J, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS, Ostrom QT (2024) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2017–2021. Neuro Oncol 26:vi1–vi85. https://doi.org/10.1093/neuonc/noae145

Article  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR, International Consortium on M (2019) Advances in multidisciplinary therapy for meningiomas. Neuro Oncol 21:i18–i31. https://doi.org/10.1093/neuonc/noy136

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F, Houdart E, Sallabanda K, Le Rhun E, Nieuwenhuizen D, Tabatabai G, Soffietti R, Weller M (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23:1821–1834. https://doi.org/10.1093/neuonc/noab150

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren L, Hua L, Bao Z, Deng J, Wang D, Chen J, Chen H, Juratli TA, Wakimoto H, Gong Y (2023) Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype. J Neurooncol 161:193–202. https://doi.org/10.1007/s11060-022-04034-3

Article  PubMed  Google Scholar 

Hua L, Zhu H, Li J, Tang H, Kuang D, Wang Y, Tang F, Chen X, Zhou L, Xie Q, Gong Y (2018) Prognostic value of Estrogen receptor in WHO grade III meningioma: a long-term follow-up study from a single institution. J Neurosurg 128:1698–1706. https://doi.org/10.3171/2017.2.JNS162566

Article  PubMed  Google Scholar 

Ren L, Hua L, Deng J, Cheng H, Wang D, Chen J, Xie Q, Wakimoto H, Gong Y (2023) Favorable Long-Term outcomes of chordoid meningioma compared with the other WHO grade 2 meningioma subtypes. Neurosurgery 92:745–755. https://doi.org/10.1227/neu.0000000000002272

Article  PubMed  Google Scholar 

Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP (2018) Intermediate-risk meningioma: initial outcomes from NRG oncology RTOG 0539. J Neurosurg 129:35–47. https://doi.org/10.3171/2016.11.JNS161170

Article  PubMed  Google Scholar 

Mahase SS, Roth O’Brien DA, No D, Roytman M, Skafida ME, Lin E, Karakatsanis NA, Osborne JR, Brandmaier A, Pannullo SC, Ramakrishna R, Stieg PE, Knisely JPS, Ivanidze J (2021) [(68)Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas. Neurooncol Adv 3:vdab012. https://doi.org/10.1093/noajnl/vdab012

Article  PubMed  PubMed Central  Google Scholar 

Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, Karakatsanis N, Ramakrishna R, Knisely J, Schwartz TH, Osborne JR, Pannullo SC (2019) Gallium-68 DOTATATE PET in the evaluation of intracranial meningiomas. J Neuroimaging 29:650–656. https://doi.org/10.1111/jon.12632

Article  PubMed  Google Scholar 

Kunz WG, Jungblut LM, Kazmierczak PM, Vettermann FJ, Bollenbacher A, Tonn JC, Schichor C, Rominger A, Albert NL, Bartenstein P, Reiser MF, Cyran CC (2017) Improved detection of transosseous meningiomas using (68)Ga-DOTATATE PET/CT compared with Contrast-Enhanced MRI. J Nucl Med 58:1580–1587. https://doi.org/10.2967/jnumed.117.191932

Article  CAS  PubMed  Google Scholar 

Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougère C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF (2019) Imaging and diagnostic advances for intracranial meningiomas. Neuro Oncol 21:i44–i61. https://doi.org/10.1093/neuonc/noy143

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nowosielski M, Galldiks N, Iglseder S, Kickingereder P, von Deimling A, Bendszus M, Wick W, Sahm F (2017) Diagnostic challenges in meningioma. Neuro Oncol 19:1588–1598. https://doi.org/10.1093/neuonc/nox101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weber DC, Lovblad KO, Rogers L (2010) New pathology classification, imagery techniques and prospective trials for meningiomas: the future looks bright. Curr Opin Neurol 23:563–570. https://doi.org/10.1097/WCO.0b013e328340441e

Article  PubMed  Google Scholar 

Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, Macke HR (2000) Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 27:273–282. https://doi.org/10.1007/s002590050034

Article  CAS  PubMed  Google Scholar 

Silva CB, Ongaratti BR, Trott G, Haag T, Ferreira NP, Leaes CG, Pereira-Lima JF, Oliveira Mda C (2015) Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance. Int J Clin Exp Pathol 8:13185–13192

CAS  PubMed  PubMed Central  Google Scholar 

Bashir A, Larsen VA, Ziebell M, Fugleholm K, Law I (2021) Improved detection of postoperative residual meningioma with [(68)Ga]Ga-DOTA-TOC PET imaging using a High-resolution research tomograph PET scanner. Clin Cancer Res 27:2216–2225. https://doi.org/10.1158/1078-0432.Ccr-20-3362

Article  CAS  PubMed  Google Scholar 

Aerts J, Ballinger JR, Behe M, Decristoforo C, Elsinga PH, Faivre-Chauvet A, Mindt TL, Kolenc Peitl P, Todde SC, Koziorowski J, European Association of Nuclear M (2014) Guidance on current good radiopharmacy practice for the small-scale Preparation of radiopharmaceuticals using automated modules: a European perspective. J Label Comp Radiopharm 57:615–620. https://doi.org/10.1002/jlcr.3227

Article  CAS  Google Scholar 

Gillings N, Hjelstuen O, Behe M, Decristoforo C, Elsinga PH, Ferrari V, Kiss OC, Kolenc P, Koziorowski J, Laverman P, Mindt TL, Ocak M, Patt M, Todde S, Walte A (2022) EANM guideline on quality risk management for radiopharmaceuticals. Eur J Nucl Med Mol Imaging 49:3353–3364. https://doi.org/10.1007/s00259-022-05738-4

Article  PubMed  PubMed Central  Google Scholar 

Jacobs F, Thierens H, Piepsz A, Bacher K, Van de Wiele C, Ham H, Dierckx RA, European Association of Nuclear M (2005) Optimised tracer-dependent dosage cards to obtain weight-independent effective doses. Eur J Nucl Med Mol Imaging 32:581–588. https://doi.org/10.1007/s00259-004-1708-5

Article  CAS  PubMed  Google Scholar 

Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci AO, Klisch TJ, Nguyen MP, Vasudevan HN, McCortney K, Yu TJ, Bhave V, Lam TC, Pu JK, Li LF, Leung GK, Chan JW, Perlow HK, Palmer JD, Haberler C, Berghoff AS, Preusser M, Nicolaides TP, Mawrin C, Agnihotri S, Resnick A, Rood BR, Chew J, Young JS, Boreta L, Braunstein SE, Schulte J, Butowski N, Santagata S, Spetzler D, Bush NAO, Villanueva-Meyer JE, Chandler JP, Solomon DA, Rogers CL, Pugh SL, Mehta MP, Sneed PK, Berger MS, Horbinski CM, McDermott MW, Perry A, Bi WL, Patel AJ, Sahm F, Magill ST, Raleigh DR (2023) Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med 29:3067–3076. https://doi.org/10.1038/s41591-023-02586-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, Ambrosini V, Kjaer A, Delgado-Bolton R, Kunikowska J, Oyen WJG, Chiti A, Giammarile F, Sundin A, Fanti S (2017) Guideline for PET/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA. Eur J Nucl Med Mol Imaging 44:1588–1601. https://doi.org/10.1007/s00259-017-3728-y

Article  CAS  PubMed  Google Scholar 

Villanueva-Meyer JE, Magill ST, Lee JC, Umetsu SE, Flavell RR (2018) Detection of metastatic meningioma to the liver using 68Ga-DOTA-Octreotate PET/CT. Clin Nucl Med 43:e338–e340. https://doi.org/10.1097/rlu.0000000000002183

Article  PubMed  Google Scholar 

Yamaga LYI, Wagner J, Funari MBG (2017) 68Ga-DOTATATE PET/CT in nonneuroendocrine tumors: A pictorial essay. Clin Nucl Med 42:e313–e316. https://doi.org/10.1097/rlu.0000000000001620

Article  PubMed  Google Scholar 

Bashir A, Broholm H, Clasen-Linde E, Vestergaard MB, Law I (2020) Pearls and pitfalls in interpretation of 68Ga-DOTATOC PET imaging. Clin Nucl Med 45:e279–e280. https://doi.org/10.1097/rlu.0000000000003012

Article  PubMed  Google Scholar 

Yilmaz B, Arslan HS, Gundogan C, Gunes MN, Cermik TF (2019) False-Positive 68Ga-DOTATATE PET/CT in active chronic prostatitis. Clin Nucl Med 44:e499–e500.